Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma

CONCLUSION: Overall, we validated the very aggressive nature of UraC, when distant metastases are present, and observed that m-UraC patients exposed to chemotherapy exhibited lower OM and CSM.PMID:34686429 | DOI:10.1016/j.urolonc.2021.09.008

Source: Urologic Oncology - October 23, 2021 Category: Urology & Nephrology Authors: Rocco Simone Flammia Francesco Chierigo Christoph W ürnschimmel Benedikt Horlemann Benedikt Hoeh Gabriele Sorce Zhen Tian Costantino Leonardo Derya Tilki Carlo Terrone Fred Saad Shahrokh F Shariat Francesco Montorsi Felix Kh Chun Michele Gallucci Pierre Source Type: research